Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy
Lithuanian University of Health Sciences
500 participants
Jan 22, 2024
OBSERVATIONAL
Conditions
Summary
This prospective observational study aims to evaluate the prognostic significance of early postoperative prostate-specific antigen (PSA) levels in patients undergoing radical prostatectomy for prostate cancer. No investigational interventions will be performed. All diagnostic procedures, follow-up assessments, and treatments will be conducted in accordance with standard clinical practice and established prostate cancer management guidelines. Participation in the study will not influence treatment decisions.
Eligibility
Inclusion Criteria4
- Patient is an adult biological male.
- Patient has morphologically confirmed and untreated prostate cancer.
- Patient who will be treated with open, laparoscopic or robot-assisted laparoscopic radical prostatectomy.
- Patient is informed about this observational study and has signed the informed consent form.
Exclusion Criteria4
- Patient has radiologically of morphologically confirmed prostate cancer metastases before the operation.
- Patient received neoadjuvant prostate cancer treatment.
- Patient is set to receive adjuvant treatment.
- Patient has any contraindications for the operation.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Radical prostatectomy for the treatment of prostate cancer. Open retropubic, laparoscopic or robot-assisted.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07516886